New Patient Appointment or 214-645-8300

Ocular Oncology

Dallas man is Texas’ first recipient of novel therapy for eye cancer that spreads to liver

After uveal melanoma spread to his liver, a Dallas man became the first patient in Texas to receive the FDA-approved Hepzato Kit at UT Southwestern.

Sanjay Chandrasekaran, M.D. / Adrienne Shannon, M.D.

July 23, 2026

Breaking ground in eye cancer research, diagnosis, and treatment

Discover advanced eye cancer treatments from UT Southwestern. Learn why proactive vision check-ups are crucial.

J. William Harbour, M.D.

April 6, 2022